Journal of the American College of Cardiology
State-of-the-Art PaperChronic Thromboembolic Pulmonary Hypertension
Key Words
Abbreviations and Acronyms
Cited by (0)
Dr. Kim has received consultancy fees for work on steering committees for Actelion and Bayer; and research support from Actelion, Aires, Gilead Sciences, Lung LLC, and United Therapeutics. Dr. Delcroix has received fees for serving as investigator, speaker, consultant, or steering committee member from Actelion, Bayer, GlaxoSmithKline, Novartis, Pfizer, and United Therapeutics; educational grants from Actelion, GlaxoSmithKline, and Pfizer; research grants from Actelion, Pfizer, and GlaxoSmithKline; and she is also holder of the Actelion Chair for Pulmonary Hypertension and of the GlaxoSmithKline chair for research and education in pulmonary vascular pathology at the KU Leuven. Dr. Jenkins has received fees for lecturing and/or serving as a trial adjudicator and steering committee member from Actelion, Bayer, GlaxoSmithKline, and Pfizer. Dr. Channick has received research grants from and/or consulted for companies that have treatments for pulmonary hypertension, including Actelion Pharmaceuticals, Bayer, United Therapeutics, and Gilead. Dr. Jansa has received fees for serving as investigator, consultant, and speaker from Actelion, Bayer, United Therapeutics, AOP Orphan Pharmaceuticals, Pfizer, and GlaxoSmithKline. Dr. Lang has received fees for serving as investigator, speaker, consultant, or steering committee member from Actelion, Bayer, GlaxoSmithKline, Novartis, Pfizer, AOP Orphan Pharmaceuticals, and United Therapeutics; educational grants from Actelion; and research grants from Actelion, AOP Orphan Pharmaceuticals, Bayer, and United Therapeutics. Dr. Madani has served as consultant for Bayer and GlaxoSmithKline; and received fees as speaker for Bayer. Dr. Pengo is on the advisory board of Daiichi-Sankyo; and has received lecture fees from Bayer AG and Roche Diagnostics. Dr. Mayer received fees for serving as speaker, consultant, or steering or adjudication committee member from Actelion, Bayer, GlaxoSmithKline, Pfizer, and AOP Orphan Pharmaceuticals. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.